FOX vs MLYS · P/E 13, rev $16.30B vs $2.17B cap
Fox Corp Class B (FOX) versus Mineralys Therapeutics, Inc. Common Stock (MLYS) — a side-by-side from cached financials, not a winner call.
Fox Corp Class B (FOX) is a entertainment company listed on US.
Mineralys Therapeutics, Inc. Common Stock (MLYS) is a biotechnology company listed on US.
Latest reported FOX revenue for 2025-06-30 was $16.30B. Net income was $2.29B. Revenue was up 16.6% from 2024-06-30 to 2025-06-30. FOX currently screens at market cap $24.49B and trailing P/E 13.0.
MLYS does not have a complete income-statement cache yet.
FOX currently screens at market cap $24.49B and trailing P/E 13.0. MLYS currently screens at market cap $2.17B.
Not investment advice. Open the FOX and MLYS stock pages for the full models.
Not investment advice.